-
Taxonomy & unit
-
ratio: %
-
Description
-
Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
-
Summary
-
4D Molecular Therapeutics, Inc. quarterly/annual Return On Equity history and growth rate from 2020 to Q3 2025.
- 4D Molecular Therapeutics, Inc. Return On Equity for the quarter ending September 30, 2025 was -47.3 %, a 68.8% decline year-over-year.
- 4D Molecular Therapeutics, Inc. annual Return On Equity for 2024 was -28.6 %, a 16.3% increase from 2023.
- 4D Molecular Therapeutics, Inc. annual Return On Equity for 2023 was -34.1 %, a 16.5% increase from 2022.
- 4D Molecular Therapeutics, Inc. annual Return On Equity for 2022 was -40.9 %, a 47.1% decline from 2021.
Return On Equity, Quarterly (%)
Return On Equity, YoY Quarterly Growth (%)
Return On Equity, Annual (%)
Return On Equity, YoY Annual Growth (%)